FDA updates information for blood donation centers

Jan. 21, 2021

The U.S. Food and Drug Administration (FDA) has updated information on its website for blood establishments about donating blood during the COVID-19 pandemic.

The website provides information on when people who have received a SARS-CoV-2 vaccine may safely donate blood.

The information is as follows:

· people who received a nonreplicating, inactivated, or mRNA-based COVID-19 vaccine can donate blood without a waiting period

· people who received a live-attenuated viral COVID-19 vaccine, refrain from donating blood for a short waiting period (e.g., 14 days) after receipt of the vaccine, 

· people who are uncertain about which COVID-19 vaccine was administered, refrain from donating for a short waiting period (e.g., 14 days) if it is possible that the individual received a live-attenuated viral vaccine.

 Visit the FDA for more news

Photo 111134338 © Kwanchaidt | Dreamstime.com
Photo 81363766 © Andrii Kucher | Dreamstime.com
Photo 125378010 © Komgrit Pradissagul | Dreamstime.com
Photo 36810879 © Tyler Olson | Dreamstime.com